Immitra Bio
Developer of a genetic medicine platform that combines hematopoietic stem cell manipulation and CRISPR-Cas9 gene editing to create precise and durable modifications in blood-forming stem cells for therapeutic development targeting rare diseases.
Industries
Biotechnology
Life Science
Biotechnology Research
Nr. of Employees
small (1-50)
Expertise Areas
- Hematopoietic stem cell gene editing
- Genetic medicine platform development
- Rare disease therapeutic development
- Preclinical translational research
Key Technologies
- CRISPR-Cas9 gene editing
- Hematopoietic stem cell manipulation
- Gene editing platform technologies
- Cell-based therapy methods